A statistically significant factor of poor prognosis was the age of patients older than 70, disease stages pT2 and pT3, lymph node involvement pN1, high grade of G3 malignancy, luminal B-like (HER2−) molecular biological tumor subtype (Figure 1). Here, ERBB2 is linked to neoplasm.